Editorial Standards
The rules, verification requirements, and separation of evidence from economics that govern every page on The Peptide Reviewer.
Evidence-first publishing
Every page on The Peptide Reviewer begins with observable, dated evidence before any editorial judgment is applied. We document what we saw, when we saw it, and how we interpreted it relative to our scoring framework. This means source files, COAs, vendor documentation, and regulatory records are published and referenced before any claim about quality, safety, or value appears on the page.
Fact-checking requirements
All vendor claims referenced on The Peptide Reviewer are cross-checked against at least one primary source — either an independent laboratory result, a regulatory filing, or an archived public statement. Third-party lab data is preferred over vendor-published documentation. When vendor-published COAs are the only available evidence, this is explicitly noted and factored into the documentation score.
Source citation standards
Every assertion about a vendor's testing, claims, regulatory posture, or sourcing is supported by a dated, linkable source. Sources are listed at the bottom of each page with the date they were verified. Unverifiable assertions are not published as fact.
Separation of editorial and commercial
Editorial staff do not set affiliate rates, negotiate sponsored placements, or participate in commercial negotiations. Affiliate relationships are managed separately and are not a factor in editorial scoring or coverage decisions. When a vendor is both reviewed and an affiliate partner, this dual relationship is disclosed prominently.
Author and reviewer attribution
Every page on The Peptide Reviewer is attributed to a named author and medically reviewed by a credentialed reviewer. Reviewer qualifications and editorial scope are published on their profile pages. Pages without named attribution are considered draft state and are not published.
Correction and update protocol
When new evidence surfaces — a vendor publishes a new COA, regulatory status changes, or a published claim is contradicted — the affected page is updated and a revision note is added. Readers and vendors can request corrections through our corrections process. Correction requests are reviewed within five business days.
Scope boundaries
The Peptide Reviewer covers documentation, testing, claims verification, and market transparency for peptide vendors. The publication does not publish medical protocols, treatment guides, dosage recommendations, or clinical guidance. Information about research-stage findings is presented with appropriate context and regulatory status.
Language and tone
Editorial content on The Peptide Reviewer is written in clear, precise language. We avoid hedging that obscures what is and is not known about a vendor or compound. We do not use sensationalized language about safety risks or product quality beyond what the evidence supports.
Verification Notes for Editorial Standards
This file is reviewed as part of the The Peptide Reviewer documentation system, which means the page is not judged by headline confidence alone. The desk checks whether the claim has a date, whether the source can be opened by a reader, whether commercial language is separated from editorial scoring, and whether a medical or regulatory boundary is visible before the reader reaches any vendor context.
For editorial standards, the practical standard is source literacy. A reader should be able to trace the page back to primary records, compare those records with the current vendor or compound claim, and see what the page does not prove. If a vendor changes a COA, removes a lab report, edits a product page, or adds health-outcome language after this review date, the conclusion can change. That is why this publication keeps source dates, correction rules, and reviewer scope close to the article body instead of hiding them in a footer.
The editorial team uses the same baseline checks across peptide vendor reviews, compound explainers, comparison pages, trust pages, and author pages. First, the page must identify the entity or topic clearly. Second, it must point readers toward primary-source verification. Third, it must avoid personal-use instructions and medical recommendations. Fourth, it must disclose when affiliate economics could exist and state that payment does not change scoring, inclusion, risk labels, or rank order.
When the page discusses a compound, the review separates published research context from research-market product claims. Published studies, trial records, or regulatory documents can describe a molecule, but they do not verify a private vendor batch. When the page discusses a vendor, the review separates a vendor's public marketing from documentation that can be checked, including batch-linked certificates, lab identity, source dates, claims language, and correction history.
Readers should treat this file as an audit trail, not a shortcut. The safest way to use it is to open the listed sources, confirm the current date on the vendor or regulatory record, and compare that source with the page summary. If the source and summary disagree, the source wins until the page is corrected. If the source cannot be found, the claim should be treated as unverified.
This added review note also gives crawlers and readers the same context that the editors use internally: what kind of evidence matters, which trust pages govern the file, who owns the review boundary, and where a correction should start. That matters most on author, policy, and directory pages because those pages can look thin even when they carry important E-E-A-T signals. The added context makes the page auditable without turning it into a new article.
- PubMed for published biomedical literature and review context.
- ClinicalTrials.gov for registered trial status and study records.
- FDA for approval status, warning letters, labeling, and regulatory context.
Frequently Asked Questions
How should I verify this page?
Start with the date, then open the primary source rather than relying on a summary. For medical or regulatory context, check PubMed, ClinicalTrials.gov, and FDA records. For vendor context, check the live vendor page, the batch-linked COA, the named lab, and any archived claim record.
Does this page provide medical advice?
No. The Peptide Reviewer publishes editorial source checks and market-transparency reviews. It does not provide treatment advice, dosing protocols, cycles, stacks, injection instructions, reconstitution guidance, diagnosis help, or personal-use recommendations.
Can affiliate relationships change the conclusion?
No. Affiliate relationships, sponsored links, and referral economics do not change scoring, inclusion, rank position, risk labels, author attribution, or medical-review status. Any paid link must be disclosed before the link and marked with sponsored nofollow attributes.
What happens if a source changes?
The page should be updated through the corrections process. A new COA, a changed vendor claim, an FDA update, or a corrected trial record can change the page. Until that update is made, readers should trust the current primary source over the older summary.
Related Standards
Methodology → · Editorial Standards → · Medical Review Policy → · Corrections Policy → · Affiliate Disclosure →